or

Cynosure gets FDA OK for laser cellulite treatment
02/05/2004 10:36 AM
Chelmsford-based Cynosure Inc., a developer and manufacturer of cosmetic and medical lasers, has received clearance from the Food and Drug Administration for the treatment of cellulite using its TriActive LaserDermology device.

The TriActive system is also used for therapeutic laser massage.

“The TriActive is used not only to tighten cellulite on the body but can be used to tighten facial skin. It is the entry-level system for any aesthetic medicine practice or medical spa,” said Michael Davin, president and chief executive officer of Cynosure, in a statement. “Patients can also combine TriActive LaserDermology treatments with other laser facial treatments, liposuction and other procedures as they wish.”

According to Davin, Cynosure is under FDA review for a laser treatment for glaucoma and has received FDA clearance for laser technology paired with fiber optics for the treatment of recurrent respiratory papilloma.

Cynosure develops, manufactures and markets laser technology products, including a pulse dye laser for vascular, birthmark and facial treatments and a family of hair removal lasers.

http://www.masshightech.com/displayarticledetail.asp?Art_ID=64742

CHELMSFORD, Mass., Feb. 4 /PRNewswire/ -- Cynosure, Inc., a leading
developer and manufacturer of cosmetic and medical lasers, announced today
that it has received government clearance for the treatment of cellulite using
its TriActive(TM) LaserDermology(SM) device. The TriActive is also used for
therapeutic laser massage.
"This clearance allows us to expand our marketing of the TriActive(TM).
Physicians and medical spas will be able to offer treatments to a wider
category of individuals. We know how concerned women are about the appearance
of cellulite. Each day on the internet alone, hundreds of searches are made
for information on treatment," said Marina Kamenakis, Director of Marketing.
"In addition, the American Academy of Dermatology has noted that,
'increasing numbers of dermatologists are realizing it's an important issue to
their patients.' We are pleased to be able to offer this newest treatment
modality to physicians and their patients."
"The TriActive is used not only to tighten cellulite on the body, but can
be used to tighten facial skin. It is the entry-level system for any aesthetic
medicine practice or medical spa," said Michael R. Davin, President and CEO.
"Patients can also combine TriActive LaserDermology treatments with other
laser facial treatments, liposuction, and other procedures as they wish."
At the 20th Annual Meeting of the American Academy of Cosmetic Surgery
(AACS), recently held in Hollywood, FL, Susan M. Boyce, M.D., presented two
abstracts on the TriActive(TM): "Intraoperative Treatment of Cellulite with
Liposuction of the Thighs" and "A Comparison Study: Triactive With and Without
the 800nm Diode Laser Component". In the latter abstract she showed that " ...
both modalities can offer some benefit to patients who are bothered by their
cellulite. However, the added benefit of the 800-nm laser component makes a
significant difference for patients." During these studies, Dr. Boyce was a
fellow with Dr. Mitchel P. Goldman, Dermatology-Cosmetic Laser Associates and
SpaMD in La Jolla, CA. She is currently in practice at the Ferguson Medical
Group in Sikeston, MO.
For more information, call Cynosure at 800-886-2966 and visit
http://www.cynosurelaser.com.

About Cynosure
Cynosure develops, manufactures, and markets laser technology products at
its Chelmsford, Massachusetts headquarters for worldwide distribution. The
company's extensive product line includes the VStar(TM) pulse dye laser for
vascular, birthmark and facial treatments, the Apogee(TM) family of hair
removal lasers, the Tri-Star(TM), Apogee(R) Elite(TM), Acclaim(TM) and
SmartEpil(TM) multi-application cosmetic lasers, the PhotoLight(R) pulsed
light system, the Tri-Active(R) LaserDermology(TM) for therapeutic laser
massage and the PhotoGenica(R) SV for surgical ENT applications.
In 2002, El. En., Italy's leading laser developer and manufacturer,
acquired a majority position of Cynosure, Inc. The product mix of the two
companies is highly complementary and will provide opportunities for growth
through an increased mix of products and wider coverage of global markets. El.
En. and Cynosure are working closely to optimize joint production processes,
research and development efforts, and to exploit worldwide distribution
channels.
Today, over 5000 of Cynosure and El.En. lasers and light-based systems are
installed around the world and are used in treating a full range of
conditions.
Cynosure has offices in the United Kingdom, France, Germany, Singapore and
Japan, and has forged a strategic partnership with Suzhou Cynosure Medical
Devices in Suzhou, Peoples Republic of China. Cynosure's global reach extends
too more than 60 nations and has given the company worldwide recognition in
physician practices.
Cynosure was founded in 1991 by Dr. Horace Furumoto, who also founded
Candela Corp.
All content and technical data on this site is the copyright of Cynosure,
Inc. 1998-2004.

Contact:
Rebekah L. Lazarou
800-886-2966 Ext. 377
rllazarou@cynosurelaser.com